• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

准分子激光屈光性角膜切削术随机前瞻性临床试验的20年随访

Twenty-year follow-up of a randomized prospective clinical trial of excimer laser photorefractive keratectomy.

作者信息

O'Brart David P S, Shalchi Zaid, McDonald Robert J, Patel Parul, Archer Timothy J, Marshall John

机构信息

Keratoconus Research Institute, Department of Ophthalmology, St. Thomas' Hospital, London, United Kingdom.

Keratoconus Research Institute, Department of Ophthalmology, St. Thomas' Hospital, London, United Kingdom.

出版信息

Am J Ophthalmol. 2014 Oct;158(4):651-663.e1. doi: 10.1016/j.ajo.2014.06.013. Epub 2014 Jun 25.

DOI:10.1016/j.ajo.2014.06.013
PMID:24973609
Abstract

PURPOSE

To investigate the 20-year efficacy and safety of photorefractive keratectomy (PRK).

DESIGN

Long-term observational case series.

METHODS

In the setting of a university hospital, a study population of 42 patients (42 eyes) who had, as part of a randomized prospective trial, undergone PRK 20 years previously were studied. All had received -3.0 or -6.0 diopter (D) corrections with either 5.0 or 6.0 mm optical zones or a multizone treatment. The mean preoperative spherical equivalent refractive error (SEQ) was -5.13 D (range, -2.75 to -8.0 D). The outcome measures included visual acuity, refractive error, corneal topography and axial length.

RESULTS

Between 1 and 20 years there was an increase in mean myopic SEQ of -0.54 D (P < 0.02). In patients younger than 40 years of age at time of correction, this increase was -0.92 D (P < 0.002) with an accompanying increase in variance (P < 0.02), whereas in those older than 40 it was -0.08D (P = 0.8). In female patients the change was -0.69D (P < 0.01), while in males it was -0.26D (P = 0.6). The efficacy index at 20 years was 0.49, and the safety index was 0.97. Corrected distance visual acuity improved between 1 and 20 years (P < 0.01); 93% of corneas were clear at 20 years; 3 eyes had trace haze. There was an improvement in haze scores between 1 and 20 years (P < 0.02). Cornea power remained unchanged between 6 months and 20 years (P = 0.4). Axial length increased by a mean of 0.84 mm (P < 0.0001). There was no ectasia.

CONCLUSIONS

There was a slight but significant increase in myopic SEQ after PRK between 1 and 20 years, particularly in those under 40 at the time of treatment and in female patients. Corneal power remained unchanged, but axial length increased. The procedure was safe, with no long-term sight-threatening complications and with improvements in corrected distance visual acuity and corneal transparency with time.

摘要

目的

研究准分子激光角膜切削术(PRK)的20年疗效及安全性。

设计

长期观察性病例系列。

方法

在一所大学医院,对42例患者(42只眼)进行研究,这些患者在20年前作为一项随机前瞻性试验的一部分接受了PRK手术。所有患者均接受了-3.0或-6.0屈光度(D)的矫正,光学区直径为5.0或6.0毫米,或采用多区治疗。术前平均等效球镜度(SEQ)为-5.13 D(范围为-2.75至-8.0 D)。观察指标包括视力、屈光不正、角膜地形图和眼轴长度。

结果

在1至20年期间,平均近视SEQ增加了-0.54 D(P < 0.02)。在矫正时年龄小于40岁的患者中,这种增加为-0.92 D(P < 0.002),同时方差增加(P < 0.02),而在40岁以上的患者中为-0.08 D(P = 0.8)。女性患者的变化为-0.69 D(P < 0.01),男性患者为-0.26 D(P = 0.6)。20年时的疗效指数为0.49,安全指数为0.97。矫正远视力在1至20年期间有所改善(P < 0.01);20年时93%的角膜透明;3只眼有微量 haze。1至20年期间haze评分有所改善(P < 0.02)。角膜屈光力在6个月至20年期间保持不变(P = 0.4)。眼轴长度平均增加了0.84毫米(P < 0.0001)。没有发生角膜扩张。

结论

PRK术后1至20年,近视SEQ有轻微但显著的增加,特别是在治疗时年龄小于40岁的患者和女性患者中。角膜屈光力保持不变,但眼轴长度增加。该手术是安全的,没有长期威胁视力的并发症,随着时间的推移,矫正远视力和角膜透明度有所改善。

相似文献

1
Twenty-year follow-up of a randomized prospective clinical trial of excimer laser photorefractive keratectomy.准分子激光屈光性角膜切削术随机前瞻性临床试验的20年随访
Am J Ophthalmol. 2014 Oct;158(4):651-663.e1. doi: 10.1016/j.ajo.2014.06.013. Epub 2014 Jun 25.
2
Effects of ablation diameter on long-term refractive stability and corneal transparency after photorefractive keratectomy.屈光性角膜切削术后消融直径对长期屈光稳定性和角膜透明度的影响。
Ophthalmology. 2006 Oct;113(10):1798-806. doi: 10.1016/j.ophtha.2006.06.030.
3
Eighteen-year follow-up of excimer laser photorefractive keratectomy.准分子激光屈光性角膜切削术的18年随访
J Cataract Refract Surg. 2015 Jan;41(1):23-32. doi: 10.1016/j.jcrs.2014.05.034. Epub 2014 Nov 20.
4
Excimer laser photorefractive keratectomy for hyperopia: 7.5-year follow-up.准分子激光光折射性角膜切削术治疗远视:7.5 年随访。
J Cataract Refract Surg. 2005 Jun;31(6):1104-13. doi: 10.1016/j.jcrs.2004.10.051.
5
A long-term study of photorefractive keratectomy; 12-year follow-up.准分子激光原位角膜磨镶术的长期研究;12年随访。
Ophthalmology. 2004 Oct;111(10):1813-24. doi: 10.1016/j.ophtha.2004.05.019.
6
Photorefractive keratectomy versus laser in situ keratomileusis for moderate to high myopia. A randomized prospective study.准分子激光角膜切削术与准分子原位角膜磨镶术治疗中高度近视的随机前瞻性研究。
Ophthalmology. 1998 Aug;105(8):1512-22, discussion 1522-3. doi: 10.1016/S0161-6420(98)98038-1.
7
Randomized bilateral comparison of excimer laser in situ keratomileusis and photorefractive keratectomy for 2.50 to 8.00 diopters of myopia.准分子激光原位角膜磨镶术与屈光性角膜切削术治疗2.50至8.00屈光度近视的随机双侧比较
Ophthalmology. 1999 Mar;106(3):447-57. doi: 10.1016/S0161-6420(99)90102-1.
8
Spherical and aspherical photorefractive keratectomy and laser in-situ keratomileusis for moderate to high myopia: two prospective, randomized clinical trials. Summit technology PRK-LASIK study group.用于中高度近视的球面和非球面光性屈光性角膜切削术及准分子原位角膜磨镶术:两项前瞻性随机临床试验。Summit技术公司PRK-LASIK研究组
Trans Am Ophthalmol Soc. 1998;96:197-221; discussion 221-7.
9
Long-term outcomes of photorefractive keratectomy for anisometropic amblyopia in children.儿童屈光参差性弱视的准分子激光角膜切削术长期疗效
Ophthalmology. 2006 Feb;113(2):169-76. doi: 10.1016/j.ophtha.2005.06.010. Epub 2005 Dec 19.
10
Ten-year follow-up of excimer laser surface ablation for myopia in thin corneas.准分子激光表面切削术治疗薄角膜近视的十年随访
Am J Ophthalmol. 2009 May;147(5):768-73, 773.e1-2. doi: 10.1016/j.ajo.2008.12.022. Epub 2009 Feb 25.

引用本文的文献

1
8-to-10-Year Follow-Up Results of Photorefractive Keratectomy and Risk Factors for Myopia Regression (Including Near Work Activity) in Southeast Iran.伊朗东南部准分子激光原位角膜磨镶术的8至10年随访结果及近视回退的危险因素(包括近距离工作活动)
Beyoglu Eye J. 2025 Jun 25;10(2):66-78. doi: 10.14744/bej.2025.82956. eCollection 2025.
2
Techniques in pediatric refractive surgery.小儿屈光手术技术
Saudi J Ophthalmol. 2023 Oct 24;38(3):214-220. doi: 10.4103/sjopt.sjopt_133_23. eCollection 2024 Jul-Sep.
3
IMI-Onset and Progression of Myopia in Young Adults.
年轻人近视的发生和进展。
Invest Ophthalmol Vis Sci. 2023 May 1;64(6):2. doi: 10.1167/iovs.64.6.2.
4
Efficacy and safety of loteprednol etabonate versus fluorometholone in the treatment of patients after corneal refractive surgery: a meta-analysis.洛度沙胺眼用凝胶与氟米龙滴眼液治疗角膜屈光手术后患者的疗效和安全性:Meta 分析。
Int Ophthalmol. 2023 Jul;43(7):2477-2486. doi: 10.1007/s10792-023-02646-w. Epub 2023 Mar 4.
5
Unexpected ocular morphological changes after corneal refractive surgery: A review.角膜屈光手术后意外的眼部形态变化:综述
Front Med (Lausanne). 2022 Nov 29;9:1014277. doi: 10.3389/fmed.2022.1014277. eCollection 2022.
6
Long-Term Visual and Refractive Stability and Ocular Biometric Changes after Laser-Assisted Subepithelial Keratomileusis for Correction of Myopia: An 8-Year Follow-Up.准分子激光上皮下角膜磨镶术矫正近视术后8年随访:长期视力、屈光稳定性及眼生物测量参数变化
J Curr Ophthalmol. 2022 Jan 6;33(4):417-421. doi: 10.4103/joco.joco_29_21. eCollection 2021 Oct-Dec.
7
Surgical outcomes of re-excimer laser phototherapeutic keratectomy (re-PTK).准分子激光光动力角膜切削术(re-PTK)的手术效果。
Sci Rep. 2021 Jun 1;11(1):11503. doi: 10.1038/s41598-021-91121-6.
8
Twenty-Year Follow-Up of Excimer Laser Photorefractive Keratectomy: A Retrospective Observational Study.准分子激光屈光性角膜切削术的20年随访:一项回顾性观察研究。
Ophthalmol Ther. 2020 Dec;9(4):917-927. doi: 10.1007/s40123-020-00281-7. Epub 2020 Jul 28.
9
Patient-reported vision-related quality of life after laser in situ keratomileusis, surface ablation, and phakic intraocular lens: The 5.5-year follow-up study.准分子原位角膜磨镶术、表面切削术和有晶状体眼人工晶状体植入术后患者报告的视力相关生活质量:5.5年随访研究。
Medicine (Baltimore). 2020 Feb;99(7):e19113. doi: 10.1097/MD.0000000000019113.
10
Refractive surgery: the most cost-saving technique in refractive errors correction.屈光手术:矫正屈光不正最具成本效益的技术。
Int J Ophthalmol. 2018 Jun 18;11(6):1013-1019. doi: 10.18240/ijo.2018.06.20. eCollection 2018.